Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Raquel, Luque Caro"'
Autor:
Daniel Herrero Rivera, Carmen Garrigós Vacas, Laura Marcos Kovandzic, Javier Puente Vázquez, Lucía A Alonso, Begoña Mellado González, Verónica Calderero Aragón, Enrique Grande, Raquel Luque Caro, Juan A Virizuela Echaburu, Juan F Rodríguez Moreno, Ainara A Etxebarria, Cristina Rodríguez-Antona, Ignacio Durán
Publikováno v:
Pharmacogenomics. 23:627-638
[Background The aim of this study was to evaluate the impact of certain single-nucleotide polymorphisms (SNPs) in cabazitaxel activity and tox]icity in patients with metastatic castration-resistant prostate cancer (mCRPC).
[Patients & methods] 5
[Patients & methods] 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48f86220b423a982c514f09867766e22
https://doi.org/10.2217/pgs-2022-0023
https://doi.org/10.2217/pgs-2022-0023
Autor:
Alicia Santiago Chinchilla, Nathalie Testart Dardel, Manuel Gómez-Río, Mercedes Zurita Herrera, Raquel Luque Caro, Gonzalo Olivares Granados, Jose M. Llamas-Elvira, Antonio Rodríguez-Fernández, Pablo Lardelli-Claret, Clara E. Chamorro Santos
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 42:886-895
The follow-up of treated low-grade glioma (LGG) requires the evaluation of subtle clinical changes and MRI results. When the result is inconclusive, additional procedures are required to assist decision-making, such as the use of advanced MRI (aMRI)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e4ffb93eb66a6e5f28e4d5b3f71f6ca
https://doi.org/10.1007/s00259-015-2997-6
https://doi.org/10.1007/s00259-015-2997-6
Publikováno v:
Cancer Translational Medicine, Vol 4, Iss 3, Pp 83-88 (2018)
Prostate tumors are the most frequent malignant cancer among men. In recent years, we have seen a significant progress in the knowledge of the carcinogenesis of prostate cancer, leading to the development of effective drugs in this scenario. Prostate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::429b5267a5d7a1d2291217f3de9297ec
https://doi.org/10.4103/ctm.ctm_14_18
https://doi.org/10.4103/ctm.ctm_14_18
Autor:
Manuel, Gómez-Río, Nathalie, Testart Dardel, Alicia, Santiago Chinchilla, Antonio, Rodríguez-Fernández, Gonzalo, Olivares Granados, Raquel, Luque Caro, Mercedes, Zurita Herrera, Clara E, Chamorro Santos, Pablo, Lardelli-Claret, José M, Llamas-Elvira
Publikováno v:
European journal of nuclear medicine and molecular imaging. 42(6)
The follow-up of treated low-grade glioma (LGG) requires the evaluation of subtle clinical changes and MRI results. When the result is inconclusive, additional procedures are required to assist decision-making, such as the use of advanced MRI (aMRI)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e7cb0a80872ce65367070f97300cf3b7
https://pubmed.ncbi.nlm.nih.gov/25808632
https://pubmed.ncbi.nlm.nih.gov/25808632
Autor:
Juan Ramón Delgado Pérez, José Antonio Ortega-Dominguez, Verónica Conde-Herrero, Aranzazu González-Vicente, Julia Ruiz-Vozmediano, Lucia Castillo-Portellano, Encarnación González-Flores, Joaquina Martínez-Galán, Cynthia González-Rivas, Beatriz González-Astorga, Raquel Luque-Caro, Jesús Soberino-García, J. García-García
Publikováno v:
Annals of Oncology. 24:iv74
Primary tumor location was pancreas in 13 pts (25.5%), lung in 11 pts (21.6%), small or large intestine in 8 pts (15.7%), appendix in 5 pts (9.8%), and other locations in 14 pts (27.5%). Results: Thirty-two pts had low grade (Ki67 20%). 49% (25) of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ff8f7136fc2b09a59c30d1def286f7d
https://doi.org/10.1093/annonc/mdt203.133
https://doi.org/10.1093/annonc/mdt203.133
Autor:
Beatriz González-Astorga, Encarnación González-Flores, Juan Ramón Delgado Pérez, J. García-García, Julia Ruiz-Vozmediano, Raquel Luque-Caro, Cynthia González-Rivas, Verónica Conde-Herrero, Lucia Castillo-Portellano, Jesús Soberino-García
Publikováno v:
Annals of Oncology. 24:iv109
Background: Bevacizumab has efficacy in first-line treatment of advanced colorectal cancer. The overall response with Bevacizumab is low in some studies. Not know the ideal method of assessing response to therapy with bevacizumab. Metabolic imaging o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ba411addbfb09032c36ac9c42d22575
https://doi.org/10.1093/annonc/mdt203.255
https://doi.org/10.1093/annonc/mdt203.255
Autor:
Marta López-Brea, Albert Font Pous, Cristina Martin Lorente, Xavier Garcia del Muro, María José Méndez Vidal, Nuria Lainez Milagro, Ignacio Duran, M. Pilar Lopez Criado, Raquel Luque Caro, Enrique Gallardo Diaz, Juan Virizuela Echaburu, Jose Angel Arranz Arija, Álvaro Pinto Marín, Mirta Garcia Alonso, M.I. Sáez, Martin Lázaro Quintela, Aranzazu Gonzalez del Alba, Sergio Vazquez Estévez, Carmen Santander Lobera, Miguel Angel Climent Duran
Publikováno v:
Journal of Clinical Oncology. 30:TPS4672-TPS4672
TPS4672 Background: Advanced transitional cell carcinoma of the urothelium (TCCU) on progression after previous cisplatin-based combination is generally an incurable disease. The appropriate management of these patients is still an unmet need. Many d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4393ff2af747343a26bc91793f016ee
https://doi.org/10.1200/jco.2012.30.15_suppl.tps4672
https://doi.org/10.1200/jco.2012.30.15_suppl.tps4672
Autor:
Julia, Ruiz-Vozmediano, Encarnación, González-Flores, Verónica, Conde-Herrero, Beatriz, González-Astorga, Javier, García-García, Cynthia, González-Rivas, Lucia, Castillo-Portellano, Lucia, Ochoa, Raquel, Luque-Caro, Ramón, Delgado Pérez Juan
Publikováno v:
In Annals of Oncology June 2014 25 Supplement 2:ii102-ii102
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.